Evogene Ltd Ord (EVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 8,511 | 5,640 | 1,675 | 930 | 1,040 |
| Cost of Goods | 2,683 | 1,692 | 909 | 767 | 574 |
| Gross Profit | 5,828 | 3,948 | 766 | 163 | 466 |
| Operating Expenses | 28,721 | 31,148 | 28,616 | 31,883 | 25,854 |
| Operating Income | -22,210 | -26,508 | -26,941 | -30,953 | -24,814 |
| Interest Expense | 3,342 | 965 | 3,329 | 1,414 | 2,951 |
| Other Income | 7,507 | 1,486 | 516 | 1,935 | 1,591 |
| Pre-tax Income | -18,045 | -25,987 | -29,754 | -30,432 | -26,174 |
| Income Tax | 9 | -33 | 90 | 13 | 32 |
| Net Income Continuous | -18,054 | -25,954 | -29,844 | -30,445 | -26,206 |
| Minority Interests | -1,569 | -2,075 | -3,206 | -2,652 | -2,832 |
| Net Income | $-16,485 | $-23,879 | $-26,638 | $-27,793 | $-23,374 |
| EPS Basic Total Ops | -2.89 | -5.20 | -6.50 | -6.90 | -8.30 |
| EPS Basic Continuous Ops | -3.17 | -5.66 | -7.24 | -7.53 | -9.31 |
| EPS Diluted Total Ops | -2.89 | -5.20 | -6.50 | -6.90 | -8.30 |
| EPS Diluted Continuous Ops | -3.17 | -5.66 | -7.24 | -7.53 | -9.31 |
| EPS Diluted Before Non-Recurring Items | -2.89 | -5.20 | -6.50 | -6.90 | -8.30 |
| EBITDA(a) | $-19,235 | $-23,896 | $-24,361 | $-28,719 | $-22,087 |